Multidrug-resistant tuberculosis around the world: what progress has been made?

Multidrug-resistant tuberculosis (MDR-TB) (resistance to at least isoniazid and rifampicin) will influence the future of global TB control. 88% of estimated MDR-TB cases occur in middle- or high-income countries, and 60% occur in Brazil, China, India, the Russian Federation and South Africa. The Wor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The European respiratory journal 2015-01, Vol.45 (1), p.150-160
Hauptverfasser:	Falzon, Dennis, Mirzayev, Fuad, Wares, Fraser, Baena, Inés Garcia, Zignol, Matteo, Linh, Nguyen, Weyer, Karin, Jaramillo, Ernesto, Floyd, Katherine, Raviglione, Mario
Format:	Artikel
Sprache:	eng
Schlagworte:	Antitubercular Agents - therapeutic use Brazil China Communicable Disease Control Data Collection Global Health Humans India Isoniazid - therapeutic use Mycobacterium Original Poverty Rifampin - therapeutic use Russia South Africa Treatment Outcome Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology World Health Organization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!